Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2008 Jul;7(7):1807–1816. doi: 10.1158/1535-7163.MCT-08-0058

Figure 4.

Figure 4

Effect of the SFK inhibitor AP23994 on Lyn kinase activity and cell proliferation. A, TC71 cells were treated with 0, 0.5, 1, or 2 nmol/L AP23994 for 1 h. Cell lysates were collected and assayed for Lyn kinase. B, TC71 cells were treated with various doses of AP23994 or DMSO for 48 h and then assayed by MTT.